Regulation of PPAR-γ gene in human promyelocytic HL-60 cell line

Leukemia Research

Volumn 27, Issue 8, 2003, Pages 683-686

  Kaul, D ^a   Anand, P K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

C myc; Cholesterol; Differentiation; Gene regulation; HL 60; Oxysterol; PPAR ; Receptor Ck induction; TPA

Indexed keywords

CELL NUCLEUS RECEPTOR; CELL SURFACE RECEPTOR; LIGAND; OXYSTEROL SPECIFIC RECEPTOR TRANSCRIPTION FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RECEPTOR CK; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; EXPERIMENTAL MODEL; GENE CONTROL; GENE FUNCTION; GENETIC ANALYSIS; HEMATOPOIESIS; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0038204249     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(02)00279-5     Document Type: Article

References (19)

1. Willtson T.M., Brown P.J., Sternback D.D., Henke B.R. The PPARs: from orphan receptor to drug discovery. J. Med. Chem. 43:2000;527.
2. Fajas L., Schoonjans K., Gelman L., Kim J.B., Najib J., Martin G.et al. Regulation of peroxisome proliferator-activated receptor γ expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism. Mol. Cell. Biol. 19:1999;5495.
3. Hayashi T., Faustman D.L. Implications of altered apoptosis in diabetes mellitus and autoimmune disease. Apoptosis. 6:2001;31.
4. Kaul D. Receptor-Ck and leukemogeneis. Leukemia Res. 22:1998;389.
5. 2 induce apoptosis in normal and malignant β-lineage cells. J. Immunol. 165:2000;6941.
6. Collins S.J. The HL-60 promyelocytic leukemia cell line: proliferation differentiation & cellular oncogene expression. Blood. 70:1987;1233.
7. k controls the expression of Bcl-2 and cyclin 'D' genes. Leukemia Res. 22:1998;671.
8. Kaul D., Varma N. Molecular mechanism involved in TPA-induced myelopoietic programming. Leukemia Res. 23:1999;235.
9. k regulates giardia encystations process. Mol. Cell. Biochem. 225:2001;167.
10. Xu D., Gruber A., Peterson C., Pisa P. Telomerase activity and the expression of telomerase components in acute myelogenous leukemia. Br. J. Haematol. 102:1998;1367.
11. Auboeuf D., Rieusset J., Fajas L., Vallier P., Frering V., Riou J.P.et al. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-α in humans. Diabetes. 46:1997;1319.
12. Kiaris H., Schally A.V. Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone. Proc. Natl. Acad. Sci. U.S.A. 96:1999;226.
13. Greene M.E., Blumberg B., McBride O.W., Yi H.F., Kronquist K., Kwan K.et al. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expr. 4:1995;281.
14. Ferman B.M., Ruan B., Chen J., Schrespter G.L., Evan R.M. The orphan nuclear receptor LxR-α is positively and negatively regulated by distinct products of mevalonate metabolism. Proc. Natl. Acad. Sci. U.S.A. 94:1997;10588.
15. Kaul D. Molecular link between cholesterol cytokines and atherogenesis. Mol. Cell. Biochem. 219:2001;65.
16. k regulates memberane-bound 125 kDa protein having affinity for genomic sterol regulatory sequence. Mol. Cell. Biochem. 216:2001;141.
17. Varma N., Varma S., Kaul D. Expression of receptor-Ck and SREBP genes in mononuclear cells from acute leukemia patients. Leukemia Res. 24:2000;913.
18. k dependent regulation of genes involved in the cell cycle. Mol. Cell. Biochem. 181:1998;137.
19. Gomez-Munoz A., Martens J.S., Steinbrecher U.P. Stimulation of phospholipase D activity by oxidized LDL in mouse peritoneal macrophages. Arterioscler. Thromb. Vasc. Biol. 20:2000;135.